Drug Shortage Report for PMS-RABEPRAZOLE EC
| Report ID | 93831 |
| Drug Identification Number | 02310813 |
| Brand name | PMS-RABEPRAZOLE EC |
| Common or Proper name | RABEPRAZOLE |
| Company Name | PHARMASCIENCE INC |
| Market Status | DORMANT |
| Active Ingredient(s) | RABEPRAZOLE SODIUM |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-09-29 |
| Actual start date | |
| Estimated end date | 2020-01-27 |
| Actual end date | 2020-02-25 |
| Shortage status | Resolved |
| Updated date | 2020-02-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-02-26 | French | Compare |
| v6 | 2020-02-26 | English | Compare |
| v5 | 2019-11-15 | French | Compare |
| v4 | 2019-11-15 | English | Compare |
| v3 | 2019-09-17 | English | Compare |
| v2 | 2019-09-12 | French | Compare |
| v1 | 2019-09-12 | English | Compare |
Showing 1 to 7 of 7